Stay updated on Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page
- Check4 days agoChange DetectedA new revision entry v3.5.5 was added to the record history, and the previous v3.5.4 entry was removed. This update represents an administrative adjustment to the study's revision history.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA new site revision entry, Revision: v3.5.4, was added to the history, superseding the previous Revision: v3.5.3.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page’s displayed ClinicalTrials.gov revision/version number has been updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check54 days agoChange DetectedAdded revision v3.5.2 to the history and removed revision v3.5.0.SummaryDifference0.0%

- Check83 days agoChange DetectedRevision: v3.5.0 was added to the history and Revision: v3.4.3 was removed from the history.SummaryDifference0.0%

- Check90 days agoChange DetectedRevision history now includes Revision: v3.4.3 and removes Revision: v3.4.2.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page.